Insider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) CEO Sells 12,219 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 12,219 shares of the stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $225,073.98. Following the transaction, the chief executive officer now owns 261,640 shares of the company’s stock, valued at $4,819,408.80. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Privia Health Group Stock Up 2.1 %

Shares of PRVA traded up $0.38 during mid-day trading on Thursday, hitting $18.41. 782,205 shares of the company’s stock were exchanged, compared to its average volume of 940,409. Privia Health Group, Inc. has a 52 week low of $17.54 and a 52 week high of $30.15. The stock’s 50-day simple moving average is $19.67 and its 200-day simple moving average is $21.16. The firm has a market cap of $2.18 billion, a price-to-earnings ratio of 96.90, a price-to-earnings-growth ratio of 2.51 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Tuesday, February 27th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.02). Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. The business had revenue of $440.80 million for the quarter, compared to the consensus estimate of $425.81 million. During the same period in the prior year, the business posted $0.14 earnings per share. The firm’s revenue for the quarter was up 21.0% compared to the same quarter last year. Analysts forecast that Privia Health Group, Inc. will post 0.26 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on PRVA shares. TD Cowen reduced their price objective on shares of Privia Health Group from $30.00 to $26.00 and set an “outperform” rating for the company in a research note on Friday, March 1st. Canaccord Genuity Group cut their target price on shares of Privia Health Group from $41.00 to $37.00 and set a “buy” rating for the company in a research note on Tuesday, March 19th. Evercore ISI cut their target price on shares of Privia Health Group from $26.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. Citigroup began coverage on shares of Privia Health Group in a research note on Monday, April 22nd. They issued a “buy” rating and a $25.00 target price for the company. Finally, JPMorgan Chase & Co. cut their target price on shares of Privia Health Group from $38.00 to $30.00 and set an “overweight” rating for the company in a research note on Wednesday, March 6th. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $27.62.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in PRVA. Maryland State Retirement & Pension System boosted its position in Privia Health Group by 3.0% in the third quarter. Maryland State Retirement & Pension System now owns 37,609 shares of the company’s stock valued at $865,000 after buying an additional 1,109 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Privia Health Group by 1.6% in the third quarter. Bank of New York Mellon Corp now owns 4,040,027 shares of the company’s stock valued at $92,921,000 after buying an additional 62,543 shares in the last quarter. New York State Teachers Retirement System boosted its position in Privia Health Group by 33.8% in the third quarter. New York State Teachers Retirement System now owns 58,204 shares of the company’s stock valued at $1,339,000 after buying an additional 14,700 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Privia Health Group by 13.8% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 20,829 shares of the company’s stock valued at $479,000 after buying an additional 2,518 shares in the last quarter. Finally, Strs Ohio lifted its holdings in shares of Privia Health Group by 42.9% during the third quarter. Strs Ohio now owns 20,000 shares of the company’s stock worth $460,000 after purchasing an additional 6,000 shares during the period. 94.48% of the stock is owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.